Is TERN undervalued or overvalued?
As of 2025-03-20, the Intrinsic Value of Terns Pharmaceuticals Inc (TERN) is -5.18 USD. This TERN valuation is based on the model Peter Lynch Fair Value. With the current market price of 3.16 USD, the upside of Terns Pharmaceuticals Inc is -264.06%. This means that TERN is overvalued by 264.06%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -5.18 - -5.18 | -5.18 | -264.06% |
| P/E | (19.29) - (19.60) | (20.30) | -742.3% |
| DDM - Stable | (12.19) - (75.46) | (43.83) | -1486.9% |
| DDM - Multi | (12.17) - (58.97) | (20.22) | -739.9% |
| Market Cap (mil) | 268.41 |
| Beta | 2.38 |
| Outstanding shares (mil) | 84.94 |
| Enterprise Value (mil) | -1.73 |
| Market risk premium | 4.60% |
| Cost of Equity | 7.59% |
| Cost of Debt | 5.00% |
| WACC | 6.28% |